GROUP-SPECIFIC DIFFERENTIATION BETWEEN HIGH- AND LOW-RISK HUMAN PAPILLOMAVIRUS GENOTYPES BY GENERAL PRIMER-MEDIATED PCR AND 2 COCKTAILS OF OLIGONUCLEOTIDE PROBES

被引:282
作者
JACOBS, MV [1 ]
HUSMAN, AMD [1 ]
VANDENBRULE, AJC [1 ]
SNIJDERS, PJF [1 ]
MEIJER, CJLM [1 ]
WALBOOMERS, JMM [1 ]
机构
[1] FREE UNIV AMSTERDAM HOSP, DEPT PATHOL, MOLEC PATHOL SECT, 1081 HV AMSTERDAM, NETHERLANDS
关键词
D O I
10.1128/JCM.33.4.901-905.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In recent years, general primer-mediated PCR assays have been developed to detect a broad spectrum of human papillomavirus (HPV) genotypes. In this study, a procedure enabling a simple group-specific differentiation of high-risk (HPV-16, -18, -31, -33, -35, -39, -45, -51, -52, -54, -56, and -58) and low-risk (HPV-6, -11, -34, 40, -42, -43, and 44) HPVs following an HPV general primer-mediated (GP5+/GP6+) PCR is presented. By computer-assisted sequence analysis, oligonucleotides (30-mers) specific for 19 different HPV genotypes were selected from the internal part of the 150-bp GP5+/GP6+-amplified region. These oligo probes were tested for specificity in a Southern blot analysis of PCR products derived from the same panel of HPV types. No cross-hybridizations were found. The sensitivities of the oligo probes varied from the femtogram level for the well-amplified HPV types like HPV-16 and -18 to the picogram level for the less-well-amplified HPV types like HPV-39 and -51. These sensitivities were reached when the oligo probes were applied both individually and in a cocktail. On the basis of these results, two cocktail oligo probes that enabled a specific and sensitive differentiation between low- and high-risk HPV types were composed.
引用
收藏
页码:901 / 905
页数:5
相关论文
共 42 条
  • [1] HUMAN PAPILLOMAVIRUSES ASSOCIATED WITH CERVICAL INTRAEPITHELIAL NEOPLASIA - GREAT DIVERSITY AND DISTINCT DISTRIBUTION IN LOW-GRADE AND HIGH-GRADE LESIONS
    BERGERON, C
    BARRASSO, R
    BEAUDENON, S
    FLAMANT, P
    CROISSANT, O
    ORTH, G
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (07) : 641 - 649
  • [2] BRINTON LA, 1992, EPIDEMIOLOGY CERVICA, P3
  • [3] CAMPION MJ, 1986, LANCET, V2, P237
  • [4] de Villiers E M, 1994, Curr Top Microbiol Immunol, V186, P1
  • [5] Delius H, 1994, Curr Top Microbiol Immunol, V186, P13
  • [6] HETEROGENEITY OF THE HUMAN PAPILLOMAVIRUS GROUP
    DEVILLIERS, EM
    [J]. JOURNAL OF VIROLOGY, 1989, 63 (11) : 4898 - 4903
  • [7] HUMAN PAPILLOMAVIRUS AND INVASIVE CERVICAL-CANCER IN BRAZIL
    ELUFNETO, J
    BOOTH, M
    MUNOZ, N
    BOSCH, FX
    MEIJER, CJLM
    WALBOOMERS, JMM
    [J]. BRITISH JOURNAL OF CANCER, 1994, 69 (01) : 114 - 119
  • [8] A GENERAL PRIMER PAIR FOR AMPLIFICATION AND DETECTION OF GENITAL HUMAN PAPILLOMAVIRUS TYPES
    EVANDER, M
    WADELL, G
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1991, 31 (2-3) : 239 - 250
  • [9] SIMULTANEOUS DETECTION AND TYPING OF GENITAL HUMAN PAPILLOMAVIRUS DNA USING THE POLYMERASE CHAIN-REACTION
    FUJINAGA, Y
    SHIMADA, M
    OKAZAWA, K
    FUKUSHIMA, M
    KATO, I
    FUJINAGA, K
    [J]. JOURNAL OF GENERAL VIROLOGY, 1991, 72 : 1039 - 1044
  • [10] HUMAN PAPILLOMAVIRUS DNA AND GENOTYPES - PROGNOSTIC FACTORS FOR PROGRESSION OF CERVICAL INTRAEPITHELIAL NEOPLASIA
    GAARENSTROOM, KN
    MELKERT, P
    WALBOOMERS, JMM
    VANDENBRULE, AJC
    VANBOMMEL, PFJ
    MEYER, CJLM
    VOORHORST, FJ
    KENEMANS, P
    HELMERHORST, TJM
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1994, 4 (02) : 73 - 78